How AI Is Aiming at the Bad Math of Drug Development

Robert Marcus
Nov 29, 2021

Related news

Sep 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Venture capitalists raise more than $100bn to target life sciences

Dec 14
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Duke U, Mayo Clinic, et al collab for innovative AI

Oct 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

Dec 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI drug discovery platform raises Series B funding

Oct 19
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Venture capital firm Sofinnova raises 472 mln euros to focus on healthcare start-ups

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

DeepMind is developing one algorithm to rule them all

Dec 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analyst reports trend in LS research funding

Nov 27
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Bright New Age of Venture Capital

Dec 29
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

IPO shows significant growth in healthcare industry

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus